Trial Profile
An Investigator Initiated Trial to Evaluate the Efficacy of Belatacept on Kidneys With Pre-existing Pathology in Patients Who Underwent Renal Transplant.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Alemtuzumab; Mycophenolate mofetil; Steroids
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 19 Aug 2015 New trial record